Bolt Biotherapeutics, Inc.
BOLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641281
In the last 90 days, Bolt Biotherapeutics, Inc. insiders filed 2 open-market purchases and 3 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $2.31M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Bolt Biotherapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- −12 vs. Q3 2022
- Shares held
- 20.6M
- −6.20M (−23.1%) vs. Q3 2022
- Total value
- $26.8M
- −$12.9M (−32.5%) vs. Q3 2022
- New holders
- 1
- 15 more added
- Sold out
- 13
- 12 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BOLT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $2.31M |
| Q1 2026 | 24 | $2.49M |
| Q4 2025 | 21 | $3.30M |
| Q3 2025 | 24 | $4.28M |
| Q2 2025 | 25 | $5.10M |
| Q1 2025 | 30 | $7.33M |
| Q4 2024 | 38 | $9.99M |
| Q3 2024 | 32 | $12.2M |
| Q2 2024 | 37 | $17.0M |
| Q1 2024 | 39 | $33.6M |
| Q4 2023 | 40 | $27.0M |
| Q3 2023 | 35 | $25.5M |
| Q2 2023 | 40 | $32.1M |
| Q1 2023 | 41 | $32.4M |
| Q4 2022 | 44 | $26.8M |
| Q3 2022 | 56 | $39.7M |
| Q2 2022 | 62 | $54.8M |
| Q1 2022 | 66 | $79.3M |
| Q4 2021 | 62 | $164.6M |
| Q3 2021 | 72 | $449.1M |
| Q2 2021 | 61 | $513.8M |
| Q1 2021 | 70 | $1.04B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Bolt Biotherapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vivo Capital, LLC | 3,871,291 | $5.03M | 0.61% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 2,754,437 | $3.58M | 0.22% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,752,162 | $3.58M | 0.00% | +1140.0% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $2.46M | 1.07% | 00.0% | Unchanged |
| Nan Fung Group Holdings Ltd | 1,166,952 | $1.52M | 1.05% | 00.0% | Unchanged |
| Newtyn Management, LLC | 1,150,000 | $1.50M | 0.31% | +550,000+91.7% | Added |
| Samsara BioCapital, LLC | 1,049,153 | $1.36M | 0.29% | 00.0% | Unchanged |
| Vanguard Group Inc | 928,276 | $1.21M | 0.00% | −11,993−1.3% | Reduced |
| OrbiMed Advisors LLC | 771,059 | $1.00M | 0.02% | 00.0% | Unchanged |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $935.5K | 0.10% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 441,539 | $574.0K | 0.00% | +47,681+12.1% | Added |
| Hawkeye Capital Management, LLC | 415,039 | $539.6K | 0.50% | 00.0% | Unchanged |
| Tang Capital Management LLC | 400,000 | $520.0K | 0.08% | +200,000+100.0% | Added |
| Goldman Sachs Group Inc | 283,028 | $367.9K | 0.00% | +270,883+2,230.4% | Added |
| Oasis Management Co Ltd. | 280,000 | $364.0K | 0.08% | 00.0% | Unchanged |
| BlackRock Inc. | 273,113 | $355.0K | 0.00% | −170,083−38.4% | Reduced |
| Millennium Management LLC | 243,401 | $316.0K | 0.00% | +125,022+105.6% | Added |
| Assenagon Asset Management S.A. | 225,816 | $294.0K | 0.00% | −54,165−19.3% | Reduced |
| Bridgeway Capital Management, LLC | 187,600 | $243.9K | 0.01% | +74,400+65.7% | Added |
| Geode Capital Management, LLC | 154,076 | $200.0K | 0.00% | +11,853+8.3% | Added |
| Privium Fund Management (UK) Ltd | 116,516 | $151.5K | 0.12% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 97,835 | $127.2K | 0.04% | +34,056+53.4% | Added |
| FMR LLC | 78,439 | $102.0K | 0.00% | −826−1.0% | Reduced |
| State Street Corp | 48,737 | $63.4K | 0.00% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 40,195 | $52.3K | 0.00% | −24,800−38.2% | Reduced |
| Morgan Stanley | 34,883 | $45.3K | 0.00% | −36,161−50.9% | Reduced |
| Northern Trust Corp | 32,279 | $42.0K | 0.00% | 00.0% | Unchanged |
| Eversept Partners, LP | 31,172 | $40.5K | 0.00% | 00.0% | Unchanged |
| Ergoteles LLC | 28,507 | $37.1K | 0.00% | −59,667−67.7% | Reduced |
| Man Group plc | 24,479 | $31.8K | 0.00% | +6,580+36.8% | Added |
| Prudential Financial Inc | 24,400 | $31.7K | 0.00% | +8,200+50.6% | Added |
| Susquehanna International Group, LLP | 20,307 | $26.4K | 0.00% | +20,307 | New |
| JPMorgan Chase & Co | 19,908 | $26.0K | 0.00% | +17,544+742.1% | Added |
| Stifel Financial Corp | 14,014 | $18.2K | 0.00% | −51−0.4% | Reduced |
| Bank of New York Mellon Corp | 12,629 | $16.4K | 0.00% | −56−0.4% | Reduced |
| Federated Hermes, Inc. | 4,029 | $5.24K | 0.00% | +1,886+88.0% | Added |
| Tower Research Capital LLC (TRC) | 2,217 | $3.00K | 0.00% | −16,320−88.0% | Reduced |
| Barclays PLC | 1,675 | $2.18K | 0.00% | +1,536+1,105.0% | Added |
| Bank of America Corp | 798 | $1.04K | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 400 | $520 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 149 | $194 | 0.00% | +4+2.8% | Added |
| Citigroup Inc | 43 | $56 | 0.00% | −450−91.3% | Reduced |
| Salem Investment Counselors Inc | 40 | $52 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 100 | $0 | 0.00% | −381−79.2% | Reduced |
| Novo Holdings A/S | 0 | $0 | 0.00% | −3,703,991−100.0% | Sold out |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −2,672,000−100.0% | Sold out |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −533,432−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −116,777−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −46,383−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −35,561−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −25,380−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −19,200−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −19,286−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −10,071−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −10,228−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −353−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −32−100.0% | Sold out |